{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:09:24Z","timestamp":1791828564104,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,3,17]],"date-time":"2015-03-17T00:00:00Z","timestamp":1426550400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s10067-015-2912-3","type":"journal-article","created":{"date-parts":[[2015,3,16]],"date-time":"2015-03-16T02:41:06Z","timestamp":1426473666000},"page":"1065-1071","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Rosuvastatin improves endothelial dysfunction in ankylosing spondylitis"],"prefix":"10.1007","volume":"34","author":[{"given":"Nidhi","family":"Garg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawan","family":"Krishan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashit","family":"Syngle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,17]]},"reference":[{"key":"2912_CR1","first-page":"S11","volume":"20","author":"D Lautermann","year":"2002","unstructured":"Lautermann D, Braun J (2002) Ankylosing spondylitis\u2014cardiac manifestations. Clin Exp Rheumatol 20:S11\u2013S15","journal-title":"Clin Exp Rheumatol"},{"key":"2912_CR2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1042\/CS20040326","volume":"109","author":"H Divecha","year":"2005","unstructured":"Divecha H, Sattar N, Rumley A, Cherry L, Lowe GD, Sturrock R (2005) Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: relevance of systemic inflammation. Clin Sci (Lond) 109:171\u2013176","journal-title":"Clin Sci (Lond)"},{"key":"2912_CR3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/BOR.0b013e328133f58e","volume":"19","author":"S Heeneman","year":"2007","unstructured":"Heeneman S, Daemen MJ (2007) Cardiovascular risks in spondyloarthritides. Curr Opin Rheumatol 19:358\u2013362","journal-title":"Curr Opin Rheumatol"},{"key":"2912_CR4","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.autrev.2005.12.006","volume":"5","author":"A Abou-Raya","year":"2006","unstructured":"Abou-Raya A, Abou-Raya S (2006) Inflammation: a pivotal link between autoimmune diseases and atherosclerosis. Autoimmun Rev 5:331\u2013337","journal-title":"Autoimmun Rev"},{"key":"2912_CR5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/ard.2003.007740","volume":"63","author":"G Vaudo","year":"2004","unstructured":"Vaudo G, Marchesi S, Gerli R, Allegrucci R, Giordano A, Siepi D, Pirro M, Shoenfeld Y, Schillaci G, Mannarino E (2004) Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis 63:31\u201335","journal-title":"Ann Rheum Dis"},{"key":"2912_CR6","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s00296-006-0147-y","volume":"26","author":"W Bilsborough","year":"2006","unstructured":"Bilsborough W, Keen H, Taylor A, O\u2019Driscoll GJ, Arnolda L, Green DJ (2006) Anti tumour necrosis factor-alpha therapy over conventional therapy improves endothelial function in adults with rheumatoid arthritis. Rheumatol Int 26:1125\u20131131","journal-title":"Rheumatol Int"},{"key":"2912_CR7","first-page":"1383","volume":"344","author":"Scandinavian Simvastatin Survival Study Group","year":"1994","unstructured":"Scandinavian Simvastatin Survival Study Group (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344:1383\u20131389","journal-title":"Lancet"},{"key":"2912_CR8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","volume":"360","author":"Heart Protection Study Collaborative Group","year":"2002","unstructured":"Heart Protection Study Collaborative Group (2002) MRC\/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomized placebo-controlled trial. Lancet 360:7\u201322","journal-title":"Lancet"},{"key":"2912_CR9","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nrd1901","volume":"4","author":"MK Jain","year":"2005","unstructured":"Jain MK, Ridker PM (2005) Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat Rev Drug Discov 4:977\u2013987","journal-title":"Nat Rev Drug Discov"},{"key":"2912_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.it.2006.12.003","volume":"28","author":"J Greenwood","year":"2007","unstructured":"Greenwood J, Mason JC (2007) Statins and the vascular endothelial inflammatory response. Trends Immunol 28:1\u201319","journal-title":"Trends Immunol"},{"key":"2912_CR11","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jacc.2007.04.076","volume":"50","author":"M Kaisa","year":"2007","unstructured":"Kaisa M, M\u00e4ki-Pet\u00e4j\u00e4 KM, Booth AD, Hall FC, Wallace SML, Brown J, McEniery CM, Wilkinson IB (2007) Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis. J Am Coll Cardiol 50:852\u2013858","journal-title":"J Am Coll Cardiol"},{"key":"2912_CR12","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1210\/jcem.87.2.8249","volume":"87","author":"KCB Tan","year":"2002","unstructured":"Tan KCB, Chow WS, Tam VHG et al (2002) Atorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilatation in type 2 diabetes mellitus. J Clin Endocrinol Metab 87:563\u2013568","journal-title":"J Clin Endocrinol Metab"},{"key":"2912_CR13","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/00005344-200011000-00011","volume":"36","author":"S Marchesi","year":"2000","unstructured":"Marchesi S, Lupattelli G, Siepi D et al (2000) Short-term atorvastatin treatment improves endothelial function in hypercholesterolemic women. J Cardiovasc Pharmacol 36:617\u2013621","journal-title":"J Cardiovasc Pharmacol"},{"key":"2912_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar4285","volume":"15","author":"O Tim\u00e1r","year":"2013","unstructured":"Tim\u00e1r O, Szekanecz Z, Kerekes G et al (2013) Rosuvastatin improves impaired endothelial function, lowers high sensitivity CRP, complement and immuncomplex production in patients with systemic sclerosis\u2014a prospective case-series study. Arthritis Res Ther 15:1\u20139","journal-title":"Arthritis Res Ther"},{"key":"2912_CR15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S Vander Linden","year":"1984","unstructured":"Vander Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361\u2013368","journal-title":"Arthritis Rheum"},{"key":"2912_CR16","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett S, Jenkinson T, Kennedy LG et al (1994) A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. J Rheumatol 21:2286\u20132291","journal-title":"J Rheumatol"},{"key":"2912_CR17","first-page":"2281","volume":"21","author":"A Calin","year":"1996","unstructured":"Calin A, Garrett S, Whitelock H et al (1996) A new approach to defining functional ability in ankylosing spondylitis: the development of the bath ankylosing spondylitis functional index. J Rheumatol 21:2281\u20132285","journal-title":"J Rheumatol"},{"key":"2912_CR18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/rheumatology\/kei145","volume":"45","author":"I Sari","year":"2006","unstructured":"Sari I, Okan T, Akar S et al (2006) Impaired endothelial function in patients with ankylosing spondylitis. Rheumatology 45:283\u2013286","journal-title":"Rheumatology"},{"key":"2912_CR19","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/ard.2007.086777","volume":"66","author":"IC Ejick Van","year":"2009","unstructured":"Van Ejick IC, Peters MJL, Seme EH, van der Horst-bruinsma IE, Dijkmans BAC, Smulders YM, Nurmohamed MT (2009) Microvascular function is impaired in ankylosing spondylitis and improves after tumour necrosis factor \u03b1 blockade. Ann Rheum Dis 66:362\u2013366","journal-title":"Ann Rheum Dis"},{"key":"2912_CR20","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.semarthrit.2004.07.010","volume":"34","author":"MJ Peters","year":"2004","unstructured":"Peters MJ, Irene E, Horst-Bruinsma V et al (2004) Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum 34:585\u2013592","journal-title":"Semin Arthritis Rheum"},{"key":"2912_CR21","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.atherosclerosis.2006.11.003","volume":"196","author":"M Caliskan","year":"2008","unstructured":"Caliskan M, Erdogan D, Gullu H et al (2008) Impaired coronary microvascular and left ventricular diastolic functions in patients with ankylosing spondylitis. Atherosclerosis 196:306\u2013312","journal-title":"Atherosclerosis"},{"key":"2912_CR22","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/rheumatology\/ken198","volume":"47","author":"S Mathieu","year":"2008","unstructured":"Mathieu S, Joly H, Baron G, Tournadre G, Dubost J-J, Ristori JM (2008) Trend towards increased arterial stiffness or intima-media thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease. Rheumatology (Oxford) 47:1203\u20131207","journal-title":"Rheumatology (Oxford)"},{"key":"2912_CR23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/03009740802279709","volume":"38","author":"A Syngle","year":"2009","unstructured":"Syngle A, Vohra K, Kaur L, Sharma S (2009) Effect of spironolactone on endothelial dysfunction in rheumatoid arthritis. Scand J Rheumatol 38:15\u201322","journal-title":"Scand J Rheumatol"},{"key":"2912_CR24","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s10067-010-1402-x","volume":"29","author":"A Syngle","year":"2010","unstructured":"Syngle A, Vohra k, Sharma A, Kaur L (2010) Endothelial dysfunction in ankylosing spondylitis improves after tumor necrosis factor-alpha blockade. Clin Rheumatol 29:763\u2013770","journal-title":"Clin Rheumatol"},{"key":"2912_CR25","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/rheumatology\/kem186","volume":"46","author":"GA Ferreira","year":"2007","unstructured":"Ferreira GA, Navarro TP, Telles RW, Andrade LEC, Sato EI (2007) Atorvastatin therapy improves endothelial-dependent vasodilation in patients with systemic lupus erythematosus: an 8 weeks controlled trial. Rheumatology 46:1560\u20131565","journal-title":"Rheumatology"},{"key":"2912_CR26","first-page":"2095","volume":"32","author":"C Tikiz","year":"2005","unstructured":"Tikiz C, Utuk O, Pirildar T et al (2005) Effects of angiotensin-converting enzyme inhibition and statin treatment on inflammatory markers and endothelial functions in patients with long term rheumatoid arthritis. J Rheumatol 32:2095\u20132101","journal-title":"J Rheumatol"},{"key":"2912_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2006.06.012","volume":"46","author":"M Ii","year":"2007","unstructured":"Ii M, Losordo DW (2007) Statins and the endothelium. Vascul Pharmacol 46:1\u20139","journal-title":"Vascul Pharmacol"},{"key":"2912_CR28","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/ard.2005.044503","volume":"65","author":"JC Denderen van","year":"2006","unstructured":"van Denderen JC, Peters MJL, van Halm VP, van der Horst-Bruinsma IE, Dijkmans BAC, Nurmohamed MT (2006) Statin therapy might be beneficial for patients with ankylosing spondylitis. Ann Rheum Dis 65:695\u2013696","journal-title":"Ann Rheum Dis"},{"key":"2912_CR29","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(04)16449-0","volume":"363","author":"DW McCarey","year":"2004","unstructured":"McCarey DW, McInnes IB, Madhok R et al (2004) Trial of atorvastatin in rheumatoid arthritis (TARA): double-blind, randomised placebo-controlled trial. Lancet 363:2015\u20132021","journal-title":"Lancet"},{"key":"2912_CR30","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.atherosclerosis.2005.06.019","volume":"185","author":"H Holschermann","year":"2006","unstructured":"Holschermann H, Schuster D, Parviz B, Haberbosch W, Tillmanns H, Muth H (2006) Statins prevent NF-kappa B transactivation independently of the IKK-pathway in human endothelial cells. Atherosclerosis 185:240\u2013245","journal-title":"Atherosclerosis"},{"key":"2912_CR31","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1136\/ard.2005.050443","volume":"65","author":"VP Halm van","year":"2006","unstructured":"van Halm VP, van Denderen JC, Peters MJL et al (2006) Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitis. Ann Rheum Dis 65:1473\u20131477","journal-title":"Ann Rheum Dis"},{"key":"2912_CR32","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/archinte.161.11.1413","volume":"161","author":"Y Cui","year":"2001","unstructured":"Cui Y, Blumenthal RS, Flaws JA et al (2001) Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med 161:1413\u20131419","journal-title":"Arch Intern Med"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-015-2912-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-015-2912-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-015-2912-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:57:40Z","timestamp":1559120260000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-015-2912-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,17]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["2912"],"URL":"https:\/\/doi.org\/10.1007\/s10067-015-2912-3","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,17]]}}}